These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 7038776

  • 1. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U, Stahl T, Hackenthal E.
    Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin-related renin release from rabbit renal cortical slices.
    Spokas EG, Wong PY, McGiff JC.
    Hypertension; 1982 Jan; 4(3 Pt 2):96-100. PubMed ID: 7040243
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
    McGiff JC, Spokas EG, Wong PY.
    Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
    [Abstract] [Full Text] [Related]

  • 4. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK, Herzer WA, Zimmerman JB, Branch RA, Oates JA, Gerkens JF.
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [Abstract] [Full Text] [Related]

  • 5. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV, Aiken JW, Shebuski RJ, Gorman RR.
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [Abstract] [Full Text] [Related]

  • 6. Formation of 6-keto prostaglandin E1 in mammalian kidneys.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 May; 79(1):149-55. PubMed ID: 6347300
    [Abstract] [Full Text] [Related]

  • 7. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY, McGiff JC, Sun FF, Lee WH.
    Eur J Pharmacol; 1979 Dec 07; 60(2-3):245-8. PubMed ID: 393526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 Oct 07; 80(2):395-402. PubMed ID: 6360281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of 6-keto-prostaglandin E1 obtained from isolated perfused kidney of the rabbit.
    Pieroni JP, Dray F, Pace-Asciak CR, McGiff JC.
    J Pharmacol Exp Ther; 1988 Oct 07; 247(1):63-8. PubMed ID: 3139870
    [Abstract] [Full Text] [Related]

  • 13. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK, Goodman RP, Fitzgerald GA, Oates JA, Branch RA.
    J Pharmacol Exp Ther; 1982 Apr 07; 221(1):183-7. PubMed ID: 7038095
    [Abstract] [Full Text] [Related]

  • 14. Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
    Jackson EK, Heidemann HT, Branch RA, Gerkens JF.
    Circ Res; 1982 Jul 07; 51(1):67-72. PubMed ID: 7044603
    [Abstract] [Full Text] [Related]

  • 15. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I, Morise T, Yasuhara S, Takeda Y, Koshida H, Takeda R.
    Br J Clin Pharmacol; 1985 Dec 07; 20(6):681-3. PubMed ID: 3912001
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of prostacyclin: formation of an active metabolite in the liver.
    Wong PY, Lee WH, Quilley CP, McGiff JC.
    Fed Proc; 1981 May 15; 40(7):2001-4. PubMed ID: 7014260
    [Abstract] [Full Text] [Related]

  • 17. Hypotensive response to prostacyclin and 6-keto-PGE1 following hepatectomy in the rat.
    Van Dam J, Stinger RB, Penhos JC, Ramwell PW, Kot PA.
    Proc Soc Exp Biol Med; 1984 Sep 15; 176(4):438-42. PubMed ID: 6379654
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
    Berry CN, Hoult JR.
    Pharmacology; 1983 Sep 15; 26(6):324-30. PubMed ID: 6348806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.